微信关注
Total item
Cart Subtotal
￥ 0.00 Purinergic (P2Y) Receptors
5 个项目
每页
-
Cangrelor Tetrasodium
Catalog No. A17919 P2Y12 receptors inhibitorCangrelor Tetrasodium is a high-affinity, reversible inhibitor of P2Y12 receptors that causes almost complete inhibition of ADP-induced platelet aggregate. It is a modified ATP derivative stable to enzymatic degradation. Unlike clopidogrel (Plavix), which is a prodrug, cangrelor is an active drug not requiring metabolic conversion. 了解更多 -
Clopidogrel thiolactone
Catalog No. A20862 P2Y12 receptor inhibitorClopidogrel thiolactone is a P2Y12 receptor inhibitor, is a potent antiplatelet agent. 了解更多 -
Prasugrel (Effient)
Catalog No. A10748 platelet inhibitorPrasugrel (Effient)是一种新型的血小板抑制剂，用于减少急性冠脉综合征（PCI）患者的血栓性心血管事件（包括支架血栓形成）。 了解更多 -
Clopidogrel
Catalog No. A21206 platelet inhibitorClopidogrel is a well-known and orally active platelet inhibitor that targets P2Y12 receptor. Clopidogrel is used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. 了解更多
5 个项目
每页